NHS Framework Agreement for Branded Pharmaceuticals for London - Tranche B and Interim Biosimilars for Midlands & East, North of England and South of England
NHS England · £710,890,000 · closes 29 Jun 2017
£710,890,000
Estimated value
Closed
Deadline
30 May 2017
Published
This tender has closed.
See what's open in medical equipment and pharmaceuticals, or get contracts like this in your inbox each morning — free.
About this contract
NHS Framework Agreement for Branded Pharmaceuticals for London - Tranche B and Interim Biosimilars for Midlands & East, North of England and South of England Offer reference number: CM/PHR/14/5446 Period of framework agreement: CM/PHR/14/5446/01 - 1 September 2017 - 31 August 2019 with an option to extend for up to 24 months CM/PHR/14/5446/02 - North of England 1September 2017 - 28 February 2018 with an option to extend for up to 6 months South of England - 1 September 2017 - 31 August 2018 with an option to extend for up to 12 months Midlands and East - 1 September 2017 - 28 February 2019 with an option to extend for up to 18 months Additional information: The procurement exercise is being conducted on the NHS England eTendering portal at www.nhsengland.bravosolution.co.uk the project code is tender_616 and the ITT code is itt_285. This is where the ITO documents are available.
Key dates
Source
Who to contact
Tender documents
Similar open tenders
Contains public sector information licensed under OGL v3.0